Search Results - "MICHAUD, Laura"

Refine Results
  1. 1
  2. 2
  3. 3

    Outcome of preoperative cefazolin use for infection prophylaxis in patients with self-reported penicillin allergy by Michaud, Laura, Yen, Hope H, Engen, Dale A, Yen, David

    Published in BMC surgery (08-02-2023)
    “…Cephalosporins are the preferred antibiotics for prophylaxis against surgical site infections. Most studies give a rate of combined IgE and non-IgE penicillin…”
    Get full text
    Journal Article
  4. 4

    Women in oncology pharmacy leadership: A white paper by Shillingburg, Alexandra, Michaud, Laura B, Schwartz, Rowena, Anderson, Jaime, Henry, David W

    Published in Journal of oncology pharmacy practice (01-01-2020)
    “…Gender disparity exists in leadership roles within healthcare. While the majority of the healthcare workforce is comprised of women, significantly fewer women…”
    Get full text
    Journal Article
  5. 5

    Incidence, Risk Factors, and Management of Infusion‐Related Reactions in Breast Cancer Patients Receiving Trastuzumab by Thompson, Lisa M., Eckmann, Karen, Boster, Bonnie L., Hess, Kenneth R., Michaud, Laura B., Esteva, Francisco J., Hortobágyi, Gabriel N., Barnett, Chad M.

    Published in The oncologist (Dayton, Ohio) (01-03-2014)
    “…Learning Objectives Identify risk factors associated with trastuzumab‐associated infusion‐related reactions. Describe the impact of premedications on the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The Epothilones: How Pharmacology Relates to Clinical Utility by Michaud, Laura Boehnke

    Published in The Annals of pharmacotherapy (01-07-2009)
    “…Objective: To review the pharmacologic properties of a novel class of chemotherapeutic agents, the epothilones, and to summarize findings from recent clinical…”
    Get full text
    Journal Article
  8. 8

    Managing cancer treatment-induced bone loss and osteoporosis in patients with breast or prostate cancer by Michaud, Laura Boehnke

    Published in American journal of health-system pharmacy (01-04-2010)
    “…To discuss trends in breast and prostate cancer prevalence and survival; risk factors for bone loss, osteoporosis, and fractures and the approach to risk…”
    Get full text
    Journal Article
  9. 9

    An Assessment of the Utilization of Complementary and Alternative Medication in Women With Gynecologic or Breast Malignancies by NAVO, Marisa A, PHAN, Julie, SMITH, Judith A, VAUGHAN, Christy, PALMER, J. Lynn, MICHAUD, Laura, JONES, Kellie L, BODURKA, Diane C, BASEN-ENGQUIST, Karen, HORTOBAGYI, Gabriel N, KAWINAGH, John J

    Published in Journal of clinical oncology (15-02-2004)
    “…To describe and assess the current utilization of complementary and alternative medicines (CAMs) in women with a diagnosis of either gynecologic or breast…”
    Get full text
    Journal Article
  10. 10

    Usage of erythropoiesis‐stimulating agents in cancer patients at an academic cancer center and experience with specific care management tools for anemia by Ferrajoli, Alessandra, Buzdar, Aman U., DeJesus, Yvette, Cheng, Lee, Michaud, Laura B., Rodriguez, Maria A.

    Published in Cancer (15-07-2011)
    “…BACKGROUND: In 2007, the US Food and Drug Administration (FDA) issued regulatory alerts for use of erythropoiesis‐stimulating agents (ESAs) in cancer patients…”
    Get full text
    Journal Article
  11. 11

    Evaluation of pharmacist-provided medication therapy management services in an oncology ambulatory setting by Watkins, Jack L., PharmD, BCOP, Landgraf, Andrea, PharmD, BCOP, Barnett, Chad M., PharmD, BCOP, Michaud, Laura, PharmD, BCOP, FASHP

    “…Abstract Objectives To determine the effect of formal medication therapy management (MTM) services on pharmacist workload, as well as to describe the…”
    Get full text
    Journal Article
  12. 12

    Oncology pharmacists in health care delivery: vital members of the cancer care team by Holle, Lisa Marie, Boehnke Michaud, Laura

    Published in Journal of oncology practice (01-05-2014)
    “…The goal of this summary is to outline the unique knowledge, skills, and functions provided by oncology pharmacists to facilitate the provision of…”
    Get full text
    Journal Article
  13. 13

    Docetaxel-Associated Epiphora by Kintzel, Polly E., Michaud, Laura B., Lange, Marianne K.

    Published in Pharmacotherapy (01-06-2006)
    “…Docetaxel is a semisynthetic taxane indicated for the treatment of advanced breast, prostate, and non–small cell lung cancers; it is also used for the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The optimal therapeutic use of ixabepilone in patients with locally advanced or metastatic breast cancer by Boehnke Michaud, Laura

    Published in Journal of oncology pharmacy practice (01-06-2009)
    “…Background. The epothilones are a new class of microtubule-stabilizing drugs that exert potent antitumor activity against taxane-resistant and multidrug…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Chemotherapy of Metastatic Breast Cancer: What to Expect in 2001 and Beyond by Esteva, Francisco J., Valero, Vicente, Pusztai, Lajos, Boehnke‐Michaud, Laura, Buzdar, Aman U., Hortobagyi, Gabriel N.

    Published in The oncologist (Dayton, Ohio) (01-01-2001)
    “…Chemotherapy plays an important role in the management of metastatic breast cancer. The anthracyclines (doxorubicin, epirubicin) and the taxanes (paclitaxel,…”
    Get full text
    Journal Article
  18. 18

    Adjuvant use of aromatase inhibitors in postmenopausal women with breast cancer by Michaud, Laura B

    Published in American journal of health-system pharmacy (01-02-2005)
    “…Emerging data from clinical trials on the use of aromatase inhibitors in the management of early-stage, hormone-dependent breast cancer in postmenopausal women…”
    Get full text
    Journal Article
  19. 19

    Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients by Jones, Kellie L, Barnett, Chad, Gauthier, Michelle, Boster, Bonnie, Espirito, Janet L, Michaud, Laura B

    Published in Journal of oncology pharmacy practice (01-03-2012)
    “…Purpose. Report descriptive outcome measures related to the quality of pharmacist-managed anticoagulation care with warfarin in patients with breast cancer…”
    Get full text
    Journal Article
  20. 20

    Treatment-experienced breast cancer by Michaud, Laura Boehnke

    Published in American journal of health-system pharmacy (15-05-2008)
    “…Breast cancer, the second leading cause of cancer mortality among women in the U.S., following lung cancer is described and the number of treatment options for…”
    Get full text
    Journal Article